Our networks

Resource Information

Breast Cancer Initiative 2.5


The Breast Cancer Initiative 2.5 (BCI2.5) represents a new commitment to unite the global breast cancer community behind a common goal to make breast health a global priority and reduce disparities in breast cancer outcomes worldwide. The initiative began as a call for action in 2014 supported by UICC, the American Cancer Society, and Susan G. Komen.

“As the most common cancer among women, breast cancer must be addressed at the global level. Progress made in high income countries has not yet been mirrored in low and middle-income countries. These differences represent a real and tangible opportunity to improve women’s lives." 

-Benjamin O. Anderson, Chair and Director of Breast Health Global Initiative, a founding member of BCI2.5

Since that initial pledge, the BCI2.5 has been engaging partners around the world, assessing need, identifying priorities and defining a strategy to meet this goal. Its consensus-based approach empowers regional champions to bring about change with the aid of its analytic, assessment and planning tools, educational materials and implementation science research methodology. The BCI2.5 delivers evidence-based technical expertise and a resource-stratified approach to improving breast health services and care at any resource level. The initiative is inclusive and encourages organizations, institutions and countries to connect and join the effort.

More information can be found on their website.



Cochrane is a global independent network of more than 30,000 researchers, professionals, patients, carers, and people interested in health. It produces reviews that summarise the best available evidence generated through research to inform decisions about health. In 2016, UICC and Cochrane signed a Memorandum of Understanding to develop and implement joint activities that support evidence-based advocacy for cancer control.

Cochrane Crowd is a citizen science platform of relevant randomizd-controlled trials to support knowledge sharing and evidence-based decision making. As a member of Cochrane crowd, you participate in efforts to catagorise and summarise healthcare evidence to support better healthcare decisions. Over 5000 participants from 118 countries have contributed to screening and citing this growing database so far. More information

Cochrane Task Exchange allows you to connect with the global Cochrane community, working with experts to complete your Cochrane reviews. On this platform, you can either post or respond to tasks, while also browsing the existing network of experts for the specific input you require. More information

PAHO Childhood Cancer Working Group

UICC has helped to establish a new regional childhood cancer network in Latin America and the Caribbean - the PAHO-led Childhood Cancer Working Group (PAHO-CCWG). The creation of a dedicated regional expert group on childhood cancer was one of the main recommendations of a policy dialogue organized by UICC in Geneva, June 2015 at the Brocher Foundation in Hermance, Switzerland. 


The policy dialogue identified a pan-regional need to address health system challenges to improve outcomes for children with cancer and to develop an advocacy agenda for countries at different levels of health system capacity across Latin America and the Caribbean.  As an initial activity, a mapping of policy, programmes and services related to childhood cancer in Latin America was started by UICC, Childhood Cancer International and the Sick Children’s Hospital in Toronto.

This mapping activity is now being undertaken in collaboration with the new WHO/PAHO regional network, which had its first meeting in Washington DC in early February 2017.

The Global Challenges Research Fund (GCRF) Research Councils UK

Research for health in conflict: Developing capability, partnerships and research in the Middle and Near East 

The Global Challenges Research Fund (GCRF) Research Councils UK are supporting research for health in conflict to understand the burden of cancer in conflict populations, beyond current epidemiology estimates, to look into specific clinical outcome and quality metrics, and case fatality rates.

Research will be conducted with national partners to model impacts, map the capacity and capabilities (workforce planning), define priority cancers, modalities and settings (prevention, treatment and care) to develop agreed, costed, and stratified  policy recommendations for pathways and models of care.

Last update: 
Monday 24 July 2017